Acambis accused of stealing trade secrets
by Brian Turner
British biotechnology firm Acambis has been accused by a rival firm of stealing trade secrets in order to develop a vaccine and win the $1.9 billion contract to supply the US with the vaccine.
Danish biotechnology firm Bavarian Nordic has filed suit in a US court alleging that Acambis used information gained from their research and their technology in order to develop their own version of the vaccine.
Bavarian Nordic is the only other company that is developing a weakened smallpox vaccine. Bavarian Nordic has also filed a complaint with the International Trade Commission in Washington, D.C., claiming that Acambis’s vaccine infringes on Bavarian Nordic’s patents on its vaccine.
Bavarian Nordic further alleges that copies of the strain of virus that it used to develop its vaccine was given to Acambis by an American government agency in February of 2003.
Analysts have said that gaining the contract is important to Acambis’s future due to losses after the end of other contracts to produce other kinds of smallpox vaccine.
Discuss this in the Finance Markets forums
Story link: Acambis accused of stealing trade secrets
Add to Bookmarks:
Related financial stories to: Acambis accused of stealing trade secrets
- Credit card companies accused of confusing customers
- Chevron accused on CNOOC bid for Unocal
- Northern Rock boss accused
- Dollar steady as trade deficit widens
- Eurofirst up 0.9 percent on slow trade day
- Crude oil prices slightly lower in early trade
- London markets up, trade volumes still low
- Trade volumes low in London again
- London markets mixed on continued low trade volumes
- UK trade deficit down in January
Previous: « China makes bid on PetroKazakhstan
Next: Investors assured as Palocci denies scandal involvement »
Visited 420 times, 2 so far today
